建发致新：公司的医疗手术机器人分销业务2025年度经营正常

Group 1 - The core viewpoint of the article is that Jianfa Zhixin (301584) expects a positive growth in its medical surgical robot distribution business for the fiscal year 2025, with revenue showing a good increase compared to 2024 [1] Group 2 - The company responded to investor inquiries on an interactive platform, indicating that its business operations are proceeding normally [1] - The anticipated revenue growth for 2025 is highlighted as a significant aspect of the company's future performance [1]